Chengshan Guo

1.1k total citations
31 papers, 759 citations indexed

About

Chengshan Guo is a scholar working on Hematology, Immunology and Rheumatology. According to data from OpenAlex, Chengshan Guo has authored 31 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Immunology and 7 papers in Rheumatology. Recurrent topics in Chengshan Guo's work include Platelet Disorders and Treatments (14 papers), Immune Cell Function and Interaction (7 papers) and Cell Adhesion Molecules Research (5 papers). Chengshan Guo is often cited by papers focused on Platelet Disorders and Treatments (14 papers), Immune Cell Function and Interaction (7 papers) and Cell Adhesion Molecules Research (5 papers). Chengshan Guo collaborates with scholars based in China, United States and Canada. Chengshan Guo's co-authors include Ming Hou, Jun Peng, Yan Shi, Ping Qin, Jianzhi Sun, Xiaojuan Zhu, Meimei Wu, Yong Zhao, Ning‐ning Shan and Xiaoxia Chu and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Frontiers in Immunology.

In The Last Decade

Chengshan Guo

31 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengshan Guo China 16 452 195 189 127 115 31 759
Ping Qin China 17 648 1.4× 216 1.1× 168 0.9× 144 1.1× 74 0.6× 45 832
Kimio Morita Japan 14 421 0.9× 90 0.5× 115 0.6× 191 1.5× 119 1.0× 24 654
Mutsumasa Yanabu Japan 16 456 1.0× 54 0.3× 138 0.7× 38 0.3× 144 1.3× 41 657
Chul‐Soo Cho South Korea 12 154 0.3× 53 0.3× 227 1.2× 40 0.3× 181 1.6× 19 602
Thomas M. Chiang United States 14 124 0.3× 87 0.4× 48 0.3× 45 0.4× 112 1.0× 37 524
Yuko Shima Japan 19 202 0.4× 312 1.6× 113 0.6× 72 0.6× 428 3.7× 61 1.2k
Tomohiro Udagawa Japan 9 97 0.2× 84 0.4× 34 0.2× 66 0.5× 198 1.7× 25 516
Yukihiro Wada Japan 17 87 0.2× 138 0.7× 198 1.0× 51 0.4× 203 1.8× 50 787
Caryl L. Campbell United States 12 93 0.2× 63 0.3× 135 0.7× 63 0.5× 161 1.4× 21 741
J. van den Born Netherlands 14 51 0.1× 55 0.3× 195 1.0× 44 0.3× 183 1.6× 25 673

Countries citing papers authored by Chengshan Guo

Since Specialization
Citations

This map shows the geographic impact of Chengshan Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengshan Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengshan Guo more than expected).

Fields of papers citing papers by Chengshan Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengshan Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengshan Guo. The network helps show where Chengshan Guo may publish in the future.

Co-authorship network of co-authors of Chengshan Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chengshan Guo. A scholar is included among the top collaborators of Chengshan Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengshan Guo. Chengshan Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jianyun, Hui Li, Qin Guo, et al.. (2021). SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients with Immune Thrombocytopenia. Stem Cells International. 2021. 1–13. 4 indexed citations
2.
Zhang, Peiyi, Hui Li, Tiantian Zhang, et al.. (2020). TNF Receptor: Fc Fusion Protein Downregulates RANKL/OPG Ratio by Inhibiting CXCL16/CXCR6 in Active Ankylosing Spondylitis. Current Pharmaceutical Biotechnology. 22(2). 305–316. 6 indexed citations
3.
Wu, Meimei, et al.. (2020). Gout: a disease involved with complicated immunoinflammatory responses: a narrative review. Clinical Rheumatology. 39(10). 2849–2859. 59 indexed citations
4.
Wang, Meiying, Peng Zhang, Jiyang Lv, et al.. (2019). Heparin and aspirin combination therapy restores T-cell phenotype in pregnant patients with antiphospholipid syndrome-related recurrent pregnancy loss. Clinical Immunology. 208. 108259–108259. 13 indexed citations
5.
Wang, Meiying, et al.. (2017). Curcumin modulation of the activation of PYK2 in peripheral blood mononuclear cells from patients with lupus nephritis. Reumatologia/Rheumatology. 55(6). 269–275. 13 indexed citations
6.
Peng, Jun, Shenglin Ma, Yu Hou, et al.. (2014). Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study. Journal of Thrombosis and Haemostasis. 12(4). 497–504. 91 indexed citations
7.
Ma, Ji, Zongtang Liu, Aixia Dou, et al.. (2013). Characterization of Th1- and Th2-associated Chemokine Receptor Expression in Spleens of Patients with Immune Thrombocytopenia. Journal of Clinical Immunology. 33(5). 938–946. 11 indexed citations
8.
Xu, Shuqian, Chunyan Wang, Xiaojuan Zhu, et al.. (2012). Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia. Annals of Hematology. 91(10). 1623–1631. 16 indexed citations
9.
Liu, Xinguang, Jinlin Li, Ping Qin, et al.. (2011). Determination of platelet-bound glycoprotein-specific autoantibodies by flow cytometric immunobead assay in primary immune thrombocytopenia. European Journal Of Haematology. 86(4). 339–346. 5 indexed citations
10.
Wang, Chunyan, Yan Shi, Yanan Min, et al.. (2011). Decreased IDO Activity and Increased TTS Expression Break Immune Tolerance in Patients with Immune Thrombocytopenia. Journal of Clinical Immunology. 31(4). 643–649. 19 indexed citations
11.
Zhao, Yong, Zhaoshun Jiang, & Chengshan Guo. (2011). New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells. Autoimmunity Reviews. 11(2). 137–142. 30 indexed citations
12.
Han, Wei, et al.. (2011). Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome. Neurogastroenterology & Motility. 24(2). 113–113. 25 indexed citations
13.
Liu, Xinguang, Juan Ren, Yuan Yu, et al.. (2011). Decreased expression of interleukin‐27 in immune thrombocytopenia. British Journal of Haematology. 153(2). 259–267. 23 indexed citations
14.
Zhao, Yong, et al.. (2010). New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes. Translational research. 155(5). 211–216. 17 indexed citations
15.
Zhu, Xiaojuan, Yan Shi, Jun Peng, et al.. (2009). The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. Blood. 114(26). 5362–5367. 78 indexed citations
16.
Zhao, Yong, David Hwang, & Chengshan Guo. (2009). Immune modulation of blood-derived stem cell as a comprehensive tool for treating type 1 diabetes.. PubMed. 8(43). 219–22. 1 indexed citations
17.
Zhu, Xiaojuan, Yan Shi, Jianzhi Sun, et al.. (2009). High-Dose Dexamethasone Inhibits BAFF Expression in Patients with Immune Thrombocytopenia. Journal of Clinical Immunology. 29(5). 603–610. 27 indexed citations
18.
Zhang, Xu, Jun Peng, Jianzhi Sun, et al.. (2008). Modulation of immune response with cytotoxic T‐lymphocyte‐associated antigen 4 immunoglobulin‐induced anergic T cells in chronic idiopathic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 6(1). 158–165. 23 indexed citations
19.
Guo, Chengshan, Qi Zhang, Jun Peng, et al.. (2008). Polarization of Natural Killer T Cells towards an NKT2 Subpopulation Occurs after Stimulation with α-Galactosylceramide and rhG-CSF in Aplastic Anemia. Acta Haematologica. 119(3). 178–186. 10 indexed citations
20.
Guo, Chengshan, Xiaoxia Chu, Yan Shi, et al.. (2007). Correction of Th1-dominant Cytokine Profiles by High-dose Dexamethasone in Patients with Chronic Idiopathic Thrombocytopenic Purpura. Journal of Clinical Immunology. 27(6). 557–562. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ping Qin Breakdown of academic impact, for papers by Kimio Morita Breakdown of academic impact, for papers by Mutsumasa Yanabu Breakdown of academic impact, for papers by Chul‐Soo Cho Breakdown of academic impact, for papers by Thomas M. Chiang Breakdown of academic impact, for papers by Yuko Shima Breakdown of academic impact, for papers by Tomohiro Udagawa Breakdown of academic impact, for papers by Yukihiro Wada Breakdown of academic impact, for papers by Caryl L. Campbell Breakdown of academic impact, for papers by J. van den Born
Rankless by CCL
2026